"Research conducted at the Angiogenesis Laboratory at Massachusetts Eye
and Ear Infirmary, has for the first time, identified the mode of death
of cone photoreceptor cells in an animal model of retinitis pigmentosa
(RP)," according to a
Medical News Today post. "This groundbreaking study, led by Demetrios G. Vavvas, M.D.,
Ph.D., and including Joan W. Miller, M.D., Mass. Eye and Ear/Mass
General Hospital Chief of Ophthalmology and Chair of Ophthalmology at
Harvard Medical School, has further identified the receptor interacting
protein (RIP) kinase pathway as a potential target for developing
treatment for vision loss in patients with retinitis pigmentosa. The
study is published in the
Proceedings of the National Academy of Sciences Early Edition."
Read more.
No comments:
Post a Comment